Home |  Contact Us | Site Map

Investor Relations

Corporate Profile

Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, e-mail us.

NASDAQ: BCRX
$11.35 + 0.13
Sep 2, 2015 at 2:39 PM ET
Intraday data provided by eSignal

Recent Releases View All Releases

BioCryst Reports Second Quarter 2015 Financial Results
RESEARCH TRIANGLE PARK, N.C., Aug. 7, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the ...

Read More

Robert Ingram Appointed to BioCryst's Board of Directors
RESEARCH TRIANGLE PARK, N.C., Aug. 6, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that Robert A. Ingram was...

Read More

Investor Relations

Rob Bennett, Vice President Investor Relations & Operations
919.859.7910
investorrelations@biocryst.com

Proxy Online

For more information click here.

Stockholder Services

Questions about stock transfers and lost certificates should be directed to the transfer agent:
American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
1-800-937-5449 (toll free in US and Canada)
1-718-921-8200 (callers outside the US and Canada)